Oppenheimer Asset Management Inc. Invitae Corp Transaction History

Oppenheimer Asset Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$7.64 - $27.5 $44,518 - $160,242	-5,827 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$15.02 - $20.57 $615 - $843	-41 Reduced 0.7%	5,827 $94,000
Q3 2019 Oct 31, 2019	SELL	$18.85 - $27.5 $1,112 - $1,622	-59 Reduced 1.0%	5,868 $113,000
Q2 2019 Aug 09, 2019	SELL	$17.37 - $26.27 $17,161 - $25,954	-988 Reduced 14.29%	5,927 $139,000
Q1 2019 Apr 24, 2019	SELL	$10.65 - $25.75 $30,309 - $73,284	-2,846 Reduced 29.16%	6,915 $162,000
Q4 2018 Jan 30, 2019	BUY	$9.26 - $16.38 $90,386 - $159,885	9,761 New	9,761 $108,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.